Novartis India Annual General Meeting
Evonile Pharma (fka Novartis India) issued a postal ballot notice for shareholder votes on ESOP 2026 grant to the MD & CEO and creation of charge on assets. E-voting runs 14 Oct–12 Nov 2026.
ALFA Filings
Every announcement, straight from the exchange
Every Novartis India annual general meeting announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Evonile Pharma (fka Novartis India) issued a postal ballot notice for shareholder votes on ESOP 2026 grant to the MD & CEO and creation of charge on assets. E-voting runs 14 Oct–12 Nov 2026.
Novartis India issued a corrigendum to its 78th AGM notice. This correction clarifies ESOP 2026 scheme details and the company's nature of industry.
Novartis India Limited submits its Annual Report for FY 2025-26 and notice for the 78th Annual General Meeting scheduled on September 24, 2026.
Novartis India shareholders approved Ms. Gowree Gokhale's appointment as Independent Director for five years via postal ballot. The resolution passed with a 99.97% majority vote.
Novartis India Limited has issued a Postal Ballot notice to seek shareholder approval for the appointment of Ms. Gowree Gokhale as a Non-Executive Independent Director for a five-year term. E-voting commences on April 17, 2026, and concludes on May 16, 2026. This follows the upcoming conclusion of Ms. Sandra Martyres' tenure.